New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies

  • Infect Immun. 2003 Nov;71(11):6292-7. doi: 10.1128/IAI.71.11.6292-6297.2003.
Timothy D Thullen  1 ,  Alan D Ashbaugh ,  Kieran R Daly ,  Michael J Linke ,  Paul E Steele ,  Peter D Walzer
Affiliations
  • 1. Veterans Affairs Medical Center, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45220, USA.
Abstract

The CD4(+) T lymphocyte plays a central role in host defense against Pneumocystis Pneumonia but has received only limited attention in rats. CD4(+) T-cell-depleting (OX-38) and nondepleting (W3/25) Monoclonal Antibodies, which recognize an identical or adjacent epitope, were administered for up to 14 weeks to Lewis rats that had been exposed to PNEUMOCYSTIS: While OX-38 produced a greater decrease in circulating CD4(+) cells than W3/25, both antibody treatments resulted in similar effects on the health of the rats and the levels of Pneumocystis Pneumonia, which were milder than those found with corticosteroids. W3/25 also did not enhance the severity of Pneumocystis Pneumonia achieved with corticosteroids alone. We conclude that CD4(+) cell function is more important than CD4(+) cell number in host defense against Pneumocystis in the rat and that this new model permits study of opportunistic infections in the rat without the confounding effects of corticosteroids.

Products